We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The drug received accelerated approval from the FDA in 2017 for treating adults with mantle cell lymphoma who have received at least one prior therapy. Read More
Statements about child-resistant packaging “are most appropriately displayed on the side panels of the carton labeling and container labels” close to storage information, the agency says. Read More
A federal court in Pennsylvania ruled that a class-action lawsuit by drug distributors against Teva and AbbVie over pay-for-delay allegations can continue. Read More
Humana claims Mallinckrodt engaged in a “complex, multipart scheme involving monopoly, bribery, racketeering, fraud, and other deceptive and unfair practices.” Read More
Rep. Elijah Cummings (D-Md.) and Sen. Bernie Sanders (I-Vt.) are going after Teva, Mylan and Heritage Pharma again for allegedly obstructing a congressional inquiry into generic drug prices. Read More